SLC5A2 and diabetes mellitus: In addition to ketoacidosis associated with poorly controlled diabetes, ketoacidosis can occur in patients with diabetes who control their blood sugar with a sodium–glucose cotransporter‐2 (SGLT2) inhibitor.